ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 27 filers reported holding ELEVATION ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,709 | +100.1% | 1,952,032 | 0.0% | 0.24% | +96.8% |
| Q4 2022 | $1,854 | -99.9% | 1,952,032 | 0.0% | 0.12% | -19.5% |
| Q3 2022 | $2,206,000 | -20.5% | 1,952,032 | -1.6% | 0.15% | -26.7% |
| Q2 2022 | $2,776,000 | -44.5% | 1,983,168 | +0.0% | 0.21% | -45.3% |
| Q1 2022 | $4,998,000 | -58.1% | 1,983,165 | 0.0% | 0.38% | -45.9% |
| Q4 2021 | $11,939,000 | -21.1% | 1,983,165 | 0.0% | 0.71% | +15.4% |
| Q3 2021 | $15,140,000 | -40.8% | 1,983,165 | 0.0% | 0.62% | -29.2% |
| Q2 2021 | $25,566,000 | – | 1,983,165 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
| Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
| venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
| TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
| Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
| DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
| Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
| CAXTON CORP | 21,813 | $14,453 | 0.06% |
| BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |